Latest News

Latest News

News from the World Hepatitis Alliance

Launch of Regional Action Plan for Viral Hepatitis in the Western Pacific 2016–2020

19 May 2016 Tara Farrell

In the Western Pacific Region, more people die from viral hepatitis than from HIV, tuberculosis and malaria combined. The Region has a quarter of the...

Welcoming two new members to the World Hepatitis Alliance

13 May 2016 Bridie Taylor

The World Hepatitis Alliance continues to grow as we welcome two new member organisations. Our membership is now made up of over 230 groups in 82...

Meeting convened to address financing the elimination of viral hepatitis in Mongolia

12 May 2016 Bridie Taylor

At the World Health Assembly later this month, 194 Member States are expected to adopt World Health Organization’s first ever Elimination Strategy...

Launch of World Hepatitis Day 2016 website and materials

29 Apr 2016 Tara Farrell

It’s that time of the year again! We are delighted to announce that the World Hepatitis Day 2016 (WHD2016) website is now available with a full set...

Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV

14 Apr 2016 Bridie Taylor

The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and...

In honour of Eduardo Pérez-Pegué

13 Apr 2016 Bridie Taylor

It is with great sadness that we learn of the loss of Eduardo Pérez Pegué. Eduardo was the first activist fighting for the rights of people living...

Research shows doctors are failing to diagnose more than 50% of patients with hepatitis C virus (HCV)

13 Apr 2016 Bridie Taylor

London, 13 April 2016 – Survey results show people living with HCV in the UK, the Netherlands and Belarus are less likely to be diagnosed than their...

WHA welcomes new Project Manager to the team

22 Mar 2016 Tara Farrell

Jessica Hicks recently joined the WHA team as a Project Manager. She will help deliver a number of projects for WHA and will drive the World...

Homie Razavi joins World Hepatitis Alliance Executive Board

18 Mar 2016 Tara Farrell

We are delighted to announce that Homie A. Razavi, PhD, has joined the World Hepatitis Alliance (WHA) Executive Board as a Non-Executive member....

HCV Quest Toolkit: Your guide to using surveys for advocacy

29 Feb 2016 Bridie Taylor

Good survey findings can make powerful tools for patient advocacy. The HCV Quest Global Patient Survey has produced compelling data on the real...

WHA Executive Board set vision for 2016 – 2017

24 Feb 2016 Bridie Taylor

On 11 – 12 February, the World Hepatitis Alliance Executive Board met in London for the annual board meeting to help set the vision for the...

Viral Hepatitis and the Sustainable Development Goals: driving action towards elimination

24 Feb 2016 Tara Farrell

Today, leading medical professionals, policymakers, civil society and patients gathered at a policy symposium organised by the Coalition to Eradicate...

World Hepatitis Day 2016 theme announced

23 Feb 2016 Bridie Taylor

With the first ever WHO Global Elimination Strategy on Viral Hepatitis set for its likely adoption at the World Health Assembly in May, 2016 will be...

Meeting an unmet need: the road from Alice Springs to Brazil

23 Feb 2016 Tara Farrell

Viral hepatitis is a major, devastating and under-recognised health issue within Indigenous communities worldwide, affecting thousands of people each...

Hepatitis C Elimination Manifesto to be launched in Brussels tomorrow

16 Feb 2016 Bridie Taylor

Tomorrow, George Kalamitsis, WHA Executive Board Member for the European Region and Charles Gore, WHA President, will join over 100 European and...

World Hepatitis Alliance seeks highly organised individual for Officer Manager vacancy

8 Feb 2016 Bridie Taylor

Make a positive change this year and join us in our fight to eliminate hepatitis. We are looking for experienced Office Manager to join our dynamic...

80% of liver cancer deaths can be prevented, saving hundreds of thousands of lives each year globally

4 Feb 2016 Tara Farrell

On World Cancer Day, the World Hepatitis Alliance is calling for the establishment of comprehensive hepatitis strategies to help prevent the 800,000...

World Hepatitis Alliance seeks motivated Project Assistant to help organise the World Hepatitis Summit

3 Feb 2016 Bridie Taylor

Make a positive change this year and join us in our fight to eliminate hepatitis. We are looking for an organised and motivated Project Assistant to...

A step towards the elimination of viral hepatitis

28 Jan 2016 Tara Farrell

Today, Member States and civil society groups convened at the World Health Organization (WHO) Executive Board (EB) meeting in Geneva to discuss the...

New addition to the WHA team

28 Jan 2016 Bridie Taylor

Preparations for the second World Hepatitis Summit (WHS2017), taking place in Brazil early 2017, are now underway and the World Hepatitis Alliance...

Pages

News from infohep

Immune modulator inarigivir looks promising for people with hepatitis B

12 Dec 2017 Liz Highleyman
Inarigivir, or SB 9200, an immune-modulating drug that has a dual mechanism of action against hepatitis B virus (HBV), reduced levels of HBV DNA, RNA...

TAF for hepatitis B improves kidney function and bone loss

30 Nov 2017 Liz Highleyman
Tenofovir alafenamide (TAF) remains effective against hepatitis B virus (HBV) for 96 weeks, with no resistance detected, according to studies...

REP 2139 combination therapy leads to functional control of hepatitis B virus

29 Nov 2017 Liz Highleyman
A majority of people with chronic hepatitis B treated with a nucleic acid polymer (REP 2139 or REP 2165) plus tenofovir and pegylated interferon were...

Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV

28 Nov 2017 Liz Highleyman
An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to a sustained response in all people with HIV and genotype 1 or 4 hepatitis C virus (HCV) in...

US approves new hepatitis B vaccine as public health agencies update guidelines

27 Nov 2017 Liz Highleyman
On 9 November the US Food and Drug Administration (FDA) approved Heplisav-B, a new vaccine that provides protection against all known subtypes of...

Model shows hepatitis C treatment is cost-effective in Japan

27 Nov 2017 Liz Highleyman
Treatment of chronic hepatitis C with direct-acting antivirals (DAAs) can lead to substantial savings by preventing the development of liver failure...

More work and lower drug prices are needed to eliminate hepatitis C worldwide

27 Nov 2017 Liz Highleyman
Eliminating hepatitis C virus (HCV) as a global public health concern is feasible, but to do this more people need to be tested and treated and...

Nivolumab improves outcomes in liver cancer study

13 Nov 2017 Liz Highleyman
Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease...

High rate of hepatitis C reinfection in German men who have sex with men

3 Nov 2017 Keith Alcorn
Around one in seven gay and bisexual men cured of hepatitis C at major treatment centres in Germany has become reinfected since 2014, according to...

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

2 Nov 2017 Keith Alcorn
Nine countries – Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, the Netherlands and Qatar – are on course to eliminate hepatitis C by...